Health
Scientists study the sensitivity of SARS-CoV-2 variants to neutralize antibodies – News-Medical.Net
The B.1.1.7 and B.1.351 variants of SARS-CoV-2 were first detected in the UK and South Africa respectively, and have since spread to many other countries.
The B.1.1.7 and B.1.351 variants of SARS-CoV-2 were first detected in the UK and South Africa respectively, and have since spread to many other countries.
Scientists from the Institut Pasteur joined forces with Orléans Regional Hospital, Tours University Hospital, Créteil Intercommunal Hospital, Strasbourg University Hospital and Georges Pompidou European Hospital to study the sensitivity of these two variants to neutralizing antibodies present in the serum samples of people who have been vaccinated…
-
General21 hours agoOf saints and sinners | The Spectator Australia
-
General21 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General21 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News12 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones